Comparison of different methods in delineating GTV of FDG PET-CT positive tissue in esophageal cancer,and validation of the results with pathological examination

( views:, downloads: )
Author:
ZHONG Xiao-jun()
YU Jin-ming()
ZHANG Bai-jiang()
MU Dian-bin()
HAN An-qin()
SONG Ping-ping()
Journal Title:
CHINESE JOURNAL OF RADIATION ONCOLOGY
Issue:
Volume 17, Issue 01, 2008
DOI:
Key Word:

Abstract´╝Ü

  • [1]Lam KY,Ma LT,Wong J.Measurement of extent of spread of esophageal squamous carcinoma by serial sectioning.J Clin Pathol,1996,49:124-129.
  • [2]Japanese Society for Esophageal Diseases,eds.Guidelines for Clinical and Pathologic Studies on Carcinoma in the Esophagus.9th.Tokyo:Kanehara Company.1999:72-82.
  • [3]Erdi YE,Rosenzweig K,Erdi AK,et al.Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography(PET).Radiother Oncol,2002,62:51-60.
  • [4]Ashamalla H,Rata S,Parikh K,et al.The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.Int J Radiat Oncol Biol Phys,2005,63:1016-1023.
  • [5]Leong T,Everitt C,Yuen K,et al.A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for esophageal cancer.Radiother Oncol,2006,78:254-261.
  • [6]Konski A,Doss M,Milestone B.et al.The integration of 18-fluorodeoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma Int J Radiat Oncol Biol Phys,2005,61:1 123-l 128.
  • [7]Sehwartz DL,Ford EC,Rajendran J,et al.FDG-PET/CT-guided intensity modulated head and neck radiotherapy:a pilot investigation.Head Neck,2005,27:478-487.
  • [8]Hicks RJ,Mac Manus MP.18F-FDG PET in candidates for radiation therapy:is it important and how do we validate its impact?J Nucl Med,2003,44:30-32.
  • [9]Daisne JF,Duprez T,Weynand B,et al.Tumor volume in pharyn golaryngeal squamous cell carcinoma:comparison at CT,MR imaging,and FDG PET and validation with surgical specimen.Radiology,2004,233:93-100.
  • [10]Erdi YE,Rosenzweig K,Erdi AK,et al.Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography(PET).Radiother Oncol,2002,62:51-60.
  • [11]Ashamalla H,Rana S,Parikh K,et al.The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.Int J Radiat Oncol Biol Phys,2005,63:1016-1023.
  • [12]Bradley J.Thomtad WL.Mutic S.et al.hnpaet of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.Int J Radiat Oncol Biol Phys,2004,59:78-86.
  • [13]Mall K,Caldwell CB,UngYC,et al.Theimpact of(18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poody defined non-small-cell lung carcinoma:a prospectire study.Int J Radiat Oncol Biol Phys,2002,52:339-350.
  • [14]Black QC,Grills IS,Kestin LL,et al.Defining a radiotherapy target with positron emission tomography.Int J Radiat Oncol Biol Phys,2004.60:1272-1282.
  • [15]Daisne JF,Sibomana M,Bol A,et al.Tri.dimensional automatic segmentation of PET volumes based on measured source-to-back-ground ratios:influence of reconstruction algorithms.Radiother Oncol,2003,69:247-250.
  • [16]Flamen P,Lerut A,Van Cutsem E,et al.Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.J Clin Oncol,2000,18:3202-3210.
  • [17]Choi JY,Lee KH,Shim YM,et al.Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.J Nucl Med,2000,41:808-815.
  • [18]Mehzer CC,Luketich JD.Friedman D.et al.Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.Clin Nucl Med,2000,25:882-887.
  • [19]Kato H.Miyazaki T.Nakajima M.et al.The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.Cancer,2005,103:148-156.
  • [20]Yoon YC,Lee KS,Shim YM,et al.Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma:CT versus FDG PET for presurgical detection prospective study.Radiology,2003,227:764-770.
  • [21]Yuan S,Yu Y,Chao KS,et al.Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.J Nucl Med,2006,47:1255-1259.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn